At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 157 enrolled
Drug / intervention
A-101 Topical Solution +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Study of A-101 Topical Solution Applied Once a Week in Subjects With Common Warts
In Brief
A Phase 2 clinical trial evaluating A-101 Topical Solution and A-101 Vehicle Solution for Common Wart. Completed, enrolled 157 participants across 17 sites.
Detailed Summary
The primary objective of this study is to evaluate the effectiveness of A-101 compared to vehicle when applied to 1 common target wart on the trunk or extremities.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCommon Wart
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
201820192020202120222023202420252026
First PostedJul 2017
Enrollment StartAug 2017
Primary CompletionMar 2018
TodayJul 2026
First PostedJul 6, 2017
Enrollment StartAug 1, 2017
Primary CompletionMar 16, 2018
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 9.0 years ago
Interventions
A-101 Topical Solutiondrug
A-101 Topical Solution
A-101 Vehicle Solutiondrug
A-101 Vehicle Solution